scispace - formally typeset
Journal ArticleDOI

The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.

Reads0
Chats0
TLDR
The outcomes showed improved results compared with historical data, and myocardial recovery was accomplished in most patients, and the 30-day mortality and complication rate was acceptable in these critical patients.
About
This article is published in The Annals of Thoracic Surgery.The article was published on 2014-01-01. It has received 107 citations till now. The article focuses on the topics: Impella & Cardiogenic shock.

read more

Citations
More filters
Journal ArticleDOI

Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device

TL;DR: In this paper, the Impella 5.0 can be used as a bridge to decision to evaluate patients for potential recovery or bridge to next therapy (bridge to heart transplantation [BTHT] or Bridge to durable left ventricular assist device or VAD [BLVAD].
Journal ArticleDOI

Complications of Temporary Percutaneous Mechanical Circulatory Support for Cardiogenic Shock: An Appraisal of Contemporary Literature.

TL;DR: Using a systems-based approach, this review covers domains of hematological, neurological, vascular, infectious, mechanical, and miscellaneous complications in the contemporary era to provide a balanced narrative and aid in risk–benefit decision-making in this acutely ill population.
Journal ArticleDOI

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock

TL;DR: Impella 5.0 allowed fast weaning of inotropes and might facilitate myocardial recovery and improve the patients’ left ventricular ejection fraction when compared to baseline, according to a multivariate analysis.
References
More filters
Journal ArticleDOI

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

TL;DR: In patients with cardiogenic shock, emergency revascularization did not significantly reduce overall mortality at 30 days, but after six months there was a significant survival benefit, and earlyRevascularization should be strongly considered for patients with acute myocardial infarction complicated by cardiogenesis.
Journal ArticleDOI

Initial Clinical Experience With Intraaortic Balloon Pumping in Cardiogenic Shock

TL;DR: Although final evaluation must await more data, balloon pumping appears to be effective in cardiogenic shock, and further study may establish a place for the procedure in myocardial infarction without cardiogenesis shock and in low cardiac output syndromes associated with open-heart surgery.
Journal ArticleDOI

Temporal trends in cardiogenic shock complicating acute myocardial infarction

TL;DR: The findings indicate no significant change in the incidence of cardiogenic shock complicating acute myocardial infarction over a 23-year period, but the short-term survival rate has increased in recent years at the same time as the use of coronary reperfusion strategies has increased.
Journal ArticleDOI

Cardiogenic Shock Complicating Acute Myocardial Infarction: Expanding the Paradigm

TL;DR: New evidence suggests that a systemic inflammatory response, complement activation, release of inflammatory cytokines, expression of inducible nitric oxide (NO) synthase (iNOS), and inappropriate vasodilation may play an important role not only in the genesis of shock but also in outcome after shock.
Related Papers (5)